Loading...

Alkermes plc Peer Comparison

Metric Value Ranking
Market Cap $5.0 Billion 4/15 ITCI
$14.0B
NBIX
$11.5B
RDY
$11.2B
ALKS
$5.0B
PBH
$4.3B
DCPH
$2.2B
ANIP
$1.4B
PCRX
$1.2B
AMPH
$1.1B
DVAX
$1.1B
COLL
$928.3M
PAHC
$907.7M
EOLS
$631.9M
IRWD
$244.8M
EGRX
$20.1M
Gross Margin 86% 6/15 IRWD
100%
ANIP
100%
NBIX
99%
DCPH
92%
ITCI
90%
ALKS
86%
PCRX
79%
EGRX
74%
EOLS
64%
RDY
59%
PBH
55%
COLL
54%
AMPH
46%
PAHC
33%
DVAX
0%
Profit Margin 34% 1/15 ALKS
34%
IRWD
34%
PBH
21%
AMPH
20%
RDY
17%
NBIX
16%
PCRX
9%
EGRX
8%
COLL
7%
PAHC
1%
DVAX
0%
ANIP
-5%
ITCI
-8%
EOLS
-9%
DCPH
-100%
EBITDA margin 42% 1/15 ALKS
42%
AMPH
35%
PBH
33%
RDY
29%
IRWD
28%
PCRX
27%
NBIX
24%
COLL
21%
EGRX
17%
ANIP
8%
PAHC
8%
EOLS
-13%
ITCI
-15%
DVAX
-100%
DCPH
-105%
Quarterly Revenue $430.0 Million 3/15 RDY
$1.0B
NBIX
$627.7M
ALKS
$430.0M
PAHC
$309.3M
PBH
$290.3M
ITCI
$199.2M
ANIP
$190.6M
PCRX
$187.3M
AMPH
$187.0M
COLL
$181.9M
IRWD
$91.6M
EOLS
$78.9M
EGRX
$64.6M
DCPH
$45.0M
DVAX
$0
Quarterly Earnings $146.5 Million 2/15 RDY
$171.1M
ALKS
$146.5M
NBIX
$103.1M
PBH
$61.0M
AMPH
$38.0M
IRWD
$31.1M
PCRX
$16.0M
COLL
$12.5M
EGRX
$5.2M
PAHC
$3.2M
DVAX
-$0
EOLS
-$6.8M
ANIP
-$10.3M
ITCI
-$16.9M
DCPH
-$45.1M
Quarterly Free Cash Flow $180.6 Million 2/15 NBIX
$235.2M
ALKS
$180.6M
COLL
$84.1M
PBH
$63.5M
PCRX
$31.0M
AMPH
$16.6M
ANIP
$13.4M
EOLS
$3.4M
DVAX
-$0
IRWD
-$0
EGRX
-$132,000
PAHC
-$4.7M
ITCI
-$12.7M
RDY
-$26.6M
DCPH
-$54.7M
Trailing 4 Quarters Revenue $1.6 Billion 3/15 RDY
$2.9B
NBIX
$2.4B
ALKS
$1.6B
PBH
$1.1B
PAHC
$1.1B
AMPH
$730.0M
PCRX
$701.0M
ITCI
$680.6M
COLL
$631.4M
ANIP
$614.4M
IRWD
$378.4M
EOLS
$265.4M
EGRX
$257.6M
DVAX
$203.9M
DCPH
$174.9M
Trailing 4 Quarters Earnings $367.1 Million 2/15 RDY
$1.0B
NBIX
$627.7M
ALKS
$430.0M
PAHC
$309.3M
PBH
$290.3M
ITCI
$199.2M
ANIP
$190.6M
PCRX
$187.3M
AMPH
$187.0M
COLL
$181.9M
IRWD
$91.6M
EOLS
$78.9M
EGRX
$64.6M
DCPH
$45.0M
DVAX
-$0
Quarterly Earnings Growth -9% 10/15 EGRX
155%
PAHC
150%
IRWD
103%
EOLS
43%
ITCI
41%
PBH
15%
AMPH
5%
RDY
2%
DCPH
2%
ALKS
-9%
NBIX
-30%
PCRX
-36%
COLL
-61%
DVAX
-100%
ANIP
-990%
Annual Earnings Growth 21% 4/15 PAHC
185%
IRWD
103%
ITCI
26%
ALKS
21%
EOLS
19%
PBH
0%
DCPH
-4%
AMPH
-13%
NBIX
-14%
COLL
-26%
RDY
-30%
DVAX
-57%
EGRX
-87%
ANIP
-160%
PCRX
-273%
Quarterly Revenue Growth 14% 10/15 ITCI
51%
ANIP
45%
DCPH
35%
EOLS
33%
PAHC
24%
NBIX
22%
COLL
22%
AMPH
20%
RDY
16%
ALKS
14%
PBH
3%
PCRX
3%
EGRX
-13%
IRWD
-19%
DVAX
-100%
Annual Revenue Growth 2% 10/15 ITCI
34%
EOLS
28%
DCPH
23%
NBIX
17%
ANIP
17%
PAHC
17%
COLL
13%
AMPH
5%
PCRX
4%
ALKS
2%
PBH
-2%
IRWD
-13%
RDY
-14%
DVAX
-23%
EGRX
-39%
Cash On Hand $291.1 Million 2/15 ITCI
$306.9M
ALKS
$291.1M
PCRX
$276.8M
NBIX
$233.0M
AMPH
$151.6M
RDY
$148.8M
ANIP
$144.9M
DVAX
$95.9M
DCPH
$91.2M
IRWD
$88.2M
EOLS
$87.0M
COLL
$70.6M
PAHC
$67.1M
PBH
$50.9M
EGRX
$15.4M
Short Term Debt $6.2 Million 7/15 RDY
$526.8M
PCRX
$210.7M
ANIP
$9.2M
EGRX
$8.3M
AMPH
$7.0M
PBH
$6.9M
ALKS
$6.2M
ITCI
$4.2M
DVAX
$4.2M
DCPH
$3.6M
IRWD
$3.2M
COLL
$1.3M
NBIX
-$0
PAHC
-$0
EOLS
-$0
Long Term Debt $69.4 Million 10/15 AMPH
$643.5M
PAHC
$622.9M
NBIX
$455.1M
PCRX
$428.2M
ANIP
$305.8M
DVAX
$250.2M
COLL
$242.7M
IRWD
$211.7M
RDY
$91.8M
ALKS
$69.4M
EGRX
$61.9M
PBH
$56.5M
DCPH
$21.4M
ITCI
$12.7M
EOLS
$0
PE 13.54 6/15 DVAX
55.78
PAHC
46.99
NBIX
33.55
RDY
22.71
PBH
20.21
ALKS
13.54
COLL
13.42
AMPH
7.18
IRWD
2.77
EGRX
1.29
PCRX
-1.00
ITCI
-1.00
ANIP
-1.00
DCPH
-1.00
EOLS
-1.00
PS 3.19 7/15 RDY
316.66
ITCI
20.64
DCPH
12.65
DVAX
5.54
NBIX
4.86
PBH
3.87
ALKS
3.19
EOLS
2.38
ANIP
2.33
PCRX
1.66
AMPH
1.57
COLL
1.47
PAHC
0.82
IRWD
0.65
EGRX
0.08
PB 3.39 6/15 EOLS
114.43
ITCI
12.23
DCPH
7.00
NBIX
4.42
PAHC
3.68
ALKS
3.39
ANIP
3.34
RDY
2.87
PBH
2.42
IRWD
1.91
DVAX
1.89
AMPH
1.56
PCRX
1.49
COLL
0.66
EGRX
0.08
PC 17.07 6/15 PBH
85.01
RDY
75.03
NBIX
49.15
ITCI
45.76
DCPH
24.26
ALKS
17.07
PAHC
13.53
COLL
13.16
DVAX
11.78
ANIP
9.87
AMPH
7.55
EOLS
7.27
PCRX
4.20
IRWD
2.78
EGRX
1.31
Liabilities to Equity 0.40 12/15 EOLS
41.12
PAHC
4.21
IRWD
2.03
ANIP
2.00
AMPH
1.15
PCRX
1.00
PBH
0.86
DVAX
0.65
EGRX
0.61
RDY
0.50
NBIX
0.44
ALKS
0.40
DCPH
0.33
ITCI
0.19
COLL
0.15
ROA 0.18 2/15 IRWD
23%
ALKS
18%
AMPH
10%
NBIX
9%
PBH
6%
COLL
4%
EGRX
4%
DVAX
2%
PAHC
2%
RDY
0%
ANIP
-1%
ITCI
-5%
PCRX
-6%
EOLS
-22%
DCPH
-45%
ROE 0.25 2/15 IRWD
69%
ALKS
25%
AMPH
22%
NBIX
13%
PBH
12%
PAHC
8%
EGRX
6%
COLL
4%
DVAX
3%
RDY
0%
ANIP
-4%
ITCI
-7%
PCRX
-13%
DCPH
-60%
EOLS
-913%
Current Ratio 3.48 4/15 COLL
6.73
ITCI
6.26
DCPH
4.01
ALKS
3.48
NBIX
3.29
RDY
3.02
EGRX
2.65
DVAX
2.53
PBH
2.16
PCRX
2.00
AMPH
1.87
ANIP
1.50
IRWD
1.49
PAHC
1.24
EOLS
1.02
Quick Ratio 1.27 4/15 DVAX
55.78
PAHC
46.99
NBIX
33.55
RDY
22.71
PBH
20.21
ALKS
13.54
COLL
13.42
AMPH
7.18
IRWD
2.77
EGRX
1.29
PCRX
-1.00
ITCI
-1.00
ANIP
-1.00
DCPH
-1.00
EOLS
-1.00
Long Term Debt to Equity 0.05 11/15 PAHC}
2.52
IRWD}
1.65
AMPH}
0.88
ANIP}
0.71
PCRX}
0.55
DVAX}
0.42
EGRX}
0.25
NBIX}
0.18
COLL}
0.15
DCPH}
0.07
ALKS}
0.05
PBH}
0.03
RDY}
0.02
ITCI}
0.01
EOLS}
0.00
Debt to Equity 0.05 13/15 EOLS
23.54
PAHC
2.52
IRWD
1.67
AMPH
0.89
PCRX
0.82
ANIP
0.74
DVAX
0.43
EGRX
0.28
NBIX
0.18
RDY
0.16
COLL
0.14
DCPH
0.08
ALKS
0.05
PBH
0.02
ITCI
0.01
Burn Rate -2.05 10/15 ITCI
16.63
EOLS
12.80
ANIP
5.84
PCRX
5.15
PAHC
3.09
DCPH
1.95
RDY
1.12
PBH
-0.89
DVAX
-1.00
ALKS
-2.05
NBIX
-2.74
IRWD
-4.04
AMPH
-14.49
EGRX
-25.01
COLL
-28.12
Cash to Cap 0.06 10/15 EGRX
0.76
IRWD
0.36
PCRX
0.24
EOLS
0.14
AMPH
0.13
ANIP
0.10
DVAX
0.08
COLL
0.08
PAHC
0.07
ALKS
0.06
DCPH
0.04
NBIX
0.02
ITCI
0.02
PBH
0.01
RDY
0.01
CCR 1.23 4/15 COLL
6.71
NBIX
2.28
PCRX
1.93
ALKS
1.23
DCPH
1.21
PBH
1.04
ITCI
0.75
AMPH
0.44
IRWD
0.00
EGRX
-0.03
RDY
-0.16
EOLS
-0.51
ANIP
-1.30
PAHC
-1.49
DVAX
EV to EBITDA 26.20 7/15 ANIP}
107.76
NBIX}
76.75
PAHC}
57.22
PBH}
44.62
PCRX}
30.13
COLL}
28.73
ALKS}
26.20
AMPH}
25.28
IRWD}
14.49
EGRX}
6.97
RDY}
1.60
DVAX}
-1.00
DCPH}
-45.43
EOLS}
-66.07
ITCI}
-472.95
EV to Revenue 3.05 6/15 ITCI
20.21
RDY
13.37
DCPH
12.27
NBIX
4.96
PBH
3.85
ALKS
3.05
ANIP
2.61
EOLS
2.54
AMPH
2.25
PCRX
2.18
COLL
1.73
PAHC
1.32
IRWD
0.98
EGRX
0.29
DVAX
-1.00